Strand Genomics, a Bangalore-based life sciences informatics company has entered into a co-marketing agreement with CombiMatrix. Under this arrangement CombiMatrix will market avadis, Strand's flagship software for microarray data analysis as a preferred solution for the CombiMatrix system. Strand and CombiMatrix will develop an interface to facilitate ordering of CombiMatrix's CustomArray products through avadis, according to a release.

"We are pleased to be able to offer our customers a high quality data analysis application along with our CustomArray products", stated Dr Amit Kumar, president and CEO of CombiMatrix. "This relationship enables us to leverage our growing sales infrastructure," he added.

"We are very pleased to work with CombiMatrix which has cutting-edge expertise in microarray technologies," said Vijay Chandru, CEO of Strand Genomics. "We strongly believe that this will be a very successful partnership and will help both CombiMatrix and Strand deliver value added products to our customers," he added further.

avadis is a data analysis and visualization tool that combines scalable analytical algorithms with powerful and interactive visualization to derive valuable insights from gene expression data.

The US-based CombiMatrix group is developing a platform technology to rapidly produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins.

CombiMatrix's technology has a wide range of applications including DNA synthesis/diagnostics, siRNA synthesis, drug discovery, and immunochemical detection.